Legal & General Group PLC Eagle Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$15.21 - $22.88 $134,836 - $202,831	-8,865 Reduced 91.54%	819 $12,000
Q2 2023 Aug 14, 2023	SELL	$17.74 - $31.87 $296,825 - $533,248	-16,732 Reduced 63.34%	9,684 $188,000
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $11,051 - $15,033	-441 Reduced 1.64%	26,416 $749,000
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $9,992 - $15,908	400 Added 1.51%	26,857 $785,000
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $28,665 - $51,125	-1,085 Reduced 3.94%	26,457 $699,000
Q2 2022 Aug 22, 2022	BUY	$41.26 - $51.35 $3,342 - $4,159	81 Added 0.29%	27,542 $1.22 Million
Q1 2022 May 16, 2022	SELL	$44.58 - $52.6 $10,922 - $12,887	-245 Reduced 0.88%	27,461 $1.36 Million
Q4 2021 Feb 14, 2022	BUY	$45.82 - $56.9 $25,063 - $31,124	547 Added 2.01%	27,706 $1.41 Million
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $88,455 - $112,675	2,020 Added 8.04%	27,159 $1.52 Million
Q2 2021 Aug 12, 2021	SELL	$36.86 - $44.5 $283,195 - $341,893	-7,683 Reduced 23.41%	25,139 $1.08 Million
Q1 2021 May 17, 2021	SELL	$40.32 - $50.97 $101,767 - $128,648	-2,524 Reduced 7.14%	32,822 $1.37 Million
Q4 2020 Feb 12, 2021	SELL	$41.72 - $51.34 $40,426 - $49,748	-969 Reduced 2.67%	35,346 $1.65 Million
Q3 2020 Nov 13, 2020	BUY	$37.02 - $51.28 $185,655 - $257,169	5,015 Added 16.02%	36,315 $1.54 Million
Q2 2020 Aug 14, 2020	BUY	$43.24 - $55.02 $106,629 - $135,679	2,466 Added 8.55%	31,300 $1.5 Million
Q1 2020 May 14, 2020	BUY	$34.37 - $60.07 $1,512 - $2,643	44 Added 0.15%	28,834 $1.33 Million
Q4 2019 Feb 13, 2020	BUY	$54.32 - $64.31 $95,331 - $112,864	1,755 Added 6.49%	28,790 $1.73 Million
Q3 2019 Nov 13, 2019	BUY	$53.25 - $59.98 $19,596 - $22,072	368 Added 1.38%	27,035 $1.53 Million
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $13,237 - $16,599	-284 Reduced 1.05%	26,667 $1.49 Million
Q1 2019 May 15, 2019	SELL	$38.66 - $51.82 $108,054 - $144,836	-2,795 Reduced 9.4%	26,951 $1.36 Million
Q4 2018 Feb 15, 2019	BUY	$36.72 - $67.73 $15,275 - $28,175	416 Added 1.42%	29,746 $1.19 Million
Q3 2018 Nov 20, 2018	BUY	$66.65 - $83.86 $771,273 - $970,427	11,572 Added 65.16%	29,330 $2.03 Million
Q2 2018 Aug 10, 2018	BUY	$51.25 - $76.62 $70,981 - $106,118	1,385 Added 8.46%	17,758 $1.35 Million
Q1 2018 May 17, 2018	BUY	$52.16 - $66.86 $7,406 - $9,494	142 Added 0.87%	16,373 $859,000
Q4 2017 Feb 13, 2018	BUY	$49.6 - $60.87 $805,057 - $987,980	16,231	16,231 $868,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account